[Protein-losing syndrome of the gastrointestinal tract].
Becker
K
K
Klinik für Innere Medizin und Gastroenterologie, Florence-Nightingale-Krankenhaus, Kaiserswerther Diakonie, Düsseldorf, Germany. becker@kaiserswerther-diakonie.de
Frieling
T
T
Erckenbrecht
J F
JF
D000328:Adult; D000465:Algorithms; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002648:Child; D018678:Cholinergic Agents / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004032:Diet; D005758:Gastritis, Hypertrophic / Q000628:therapy; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008201:Lymphangiectasis, Intestinal / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D015282:Octreotide / Q000627:therapeutic use; D011413:Propantheline / Q000627:therapeutic use; D011504:Protein-Losing Enteropathies / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
D000897:Anti-Ulcer Agents; D018678:Cholinergic Agents; D005765:Gastrointestinal Agents; D007166:Immunosuppressive Agents; D011413:Propantheline; D002927:Cimetidine; D003520:Cyclophosphamide; D015282:Octreotide